FTII: FutureTech II Acquisition Corp. Stock

by  •  • Comments Off on FTII: FutureTech II Acquisition Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 48.91
Enterprise Value ($M) 53.03
Book Value ($M) -9.37
Book Value / Share -2.18
Price / Book -5.22
NCAV ($M) -18.39
NCAV / Share -4.29
Price / NCAV -2.66

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.04
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.28
Current Ratio 0.28

Balance Sheet (mrq) ($M)
Current Assets 2.05
Assets 11.07
Liabilities 20.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -1.81
Net Income -0.75
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.93
Cash from Investing 36.86
Cash from Financing -34.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Walleye Capital LLC 0.00 -100.00
05-14 13G/A Hudson Bay Capital Management LP 4.65 -0.35
05-02 13G/A Calamos Investment Trust/il 11.60 -0.72
11-14 13G/A Polar Asset Management Partners Inc. 0.00 -100.00
11-13 13G/A Aqr Capital Management Llc 0.00 -100.00
11-13 13G/A Cowen And Company, Llc 4.10 -67.65
06-07 13G/A Karpus Management, Inc. 2.34 -82.72

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
FFNTF – 4Front Ventures Corp. FNCH – Finch Therapeutics Group, Inc.
FPMI – FluoroPharma Medical, Inc. GBIM – GlobeImmune, Inc.
GCAN – The Greater Cannabis Company, Inc.


Financial data and stock pages provided by
Fintel.io